|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||309.33 g/mol g·mol−1|
|3D model (JSmol)|
CRL-40,940 (also known as flmodafinil, bisfluoromodafinil and lauflumide) is the bisfluoro analog of modafinil. It is a eugeroic as well as a weak dopamine reuptake inhibitor. Its inventors claim that it is more effective than modafinil and adrafinil, with fewer side effects. It was patented in 2013, and Phase I clinical trials have been underway since December 2015.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|